Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-08-14
1989-04-11
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548253, C07D40306, C07D25704, A61K 3141
Patent
active
048207225
ABSTRACT:
The instant invention provides disubstituted tetrazoles that antagonizes the effect of leukotrienes C.sub.4, D.sub.4 and E.sub.4 in selected tissues. The disubstituted tetrazoles are used in pharmaceutical formulations and methods of treatment of conditions caused by excessive amounts of leukotrienes C.sub.4, D.sub.4 or E.sub.4 or any combination thereof.
Carr F. Patrick
Dillard Robert D.
Marshall Winston S.
McCullough Doris E.
Conrad Robert A.
Eli Lilly and Company
Springer David B.
Whitaker Leroy
LandOfFree
Disubstituted tetrazoles and their use as leukotriene antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Disubstituted tetrazoles and their use as leukotriene antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disubstituted tetrazoles and their use as leukotriene antagonist will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-667516